組織工程雜志的宗旨是為組織工程研究及其臨床應(yīng)用的出版提供一個(gè)嚴(yán)格的同行評(píng)審和高質(zhì)量的論壇。組織工程領(lǐng)域本質(zhì)上是多學(xué)科的，需要細(xì)胞生物學(xué)、生物物理學(xué)、材料和生物材料科學(xué)以及臨床應(yīng)用的知識(shí)和/或理解，這一基本原理直接適用于本雜志。組織工程的主要目的是恢復(fù)、維持和/或改善組織或器官的功能，這可能受到細(xì)胞與物質(zhì)基質(zhì)結(jié)合使用的影響，也可能結(jié)合適當(dāng)?shù)纳L和指導(dǎo)因素。該雜志具有廣泛的興趣，從干細(xì)胞和祖細(xì)胞的基本原理及其擴(kuò)展到活的數(shù)量，再加上對(duì)其分化的理解，利用生物反應(yīng)器進(jìn)行三維培養(yǎng)和表型變化的研究，特別是在干細(xì)胞和祖細(xì)胞中，短期和長期，體內(nèi)和體外植入，臨床前模型和臨床試驗(yàn)。

The aim of Journal of Tissue Engineering is to provide a rigorously peer-reviewed and high quality forum for the publication of tissue engineering research and its clinical application. The field of tissue engineering by its very nature is multidisciplinary requiring knowledge and/or understanding of cell biology, biophysics, materials and biomaterials science and clinical applicability and this rationale is directly applicable to this journal.The primary aim as enshrined in the definition of tissue engineering is to restore, maintain and/or improve tissue or organ function and this may be effected by the use of cells in combination with material substrates and also may be coupled with appropriate growth and guidance factors.The journal has broad ranging interests from the fundamentals of stem cells and progenitor cells and their expansion to viable numbers coupled with an understanding of their differentiation, the utilisation of bioreactors for three dimensional culture and studies of phenotypic changes, particularly in stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.